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  Several anti－cancer drugs have been reported to’be’carcinogenic and s6me of these are suspected
of being carcinogenic in man．
  A high correlation between the mutagenicity and carcinogenicity of anti－cancer drugs has been
rePorted，． Therefore， it is very important to deterrrline the presence of mutagens in the urine of
patients treated with anti－cancer drugs．
  Theye are some problems in the deteetion of mutagens in human urine in the Salmonella system．
Prior to the investigation of human urine， a preliminary experiment was carried out with rats．
  We have reported that nine of 21anti－cancer drugs showed the ability to cause皿utatiQns in Sal－
monella typhimurium test strains and the urine．frotn rats treated with six of 7 mutagemic drugs was
mutagenlc，
  Six new anti－cancer drugs， ACNU， BCNU， lfospharnide， Mithramycin， Natulan and CDDP，
weice tested． Three drugs， ACNU， BCNU and CDDP， showed mutagenicity． After six drugs were
injected continuously into the juglar veins of rats， urine was coilected through a cystostomy tube and
tested for mutagenicity． The urine from rats treated With three drugs， BCNU， lfosphamide and CDDP，
was mutagemc．




























実 験 方 法














Table 1． Mutagenicity of anti－cancer drugs．
             Revertant colonies／piatea







































































Controi （ DMSO｝ 3i
Sodium a2ide’40 1／505
a ：average of 5 plates














TA98にはnitrofluoren 40μ9／0．1ml dimcthyl sul－
foxidc（DMSO）， TAIooにはsodium azide IOO P9／
0，1ml Salineを用いた19）．














































Table 2． Mutation assay for rat urine treated with antl－cancer drugs．
Anti－cancer drugs    urine volumedose     （ml）
RevertQnt colonies per plateO

















































a： average ot 3 plat．es
816 泌尿紀要 26巻 7号 1980年
Table 3． Carcinogenicity and ，mutagenicity of anti－cancer drugs．


























































 1） Salmonella t）phimurium TA98とTA100を用い
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